Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine-based anticancer regimens in daily clinical care

Author(s):
Meulensdijks, D.; Hasselt, J.G.C. van; Huitema, A.D.R.; Tinteren, H. van; Deenen, M.J; Beijnen, J.H.; Cats, A.; Schellens, J.H.M.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016
Is part of
European Journal of Cancer (2016), Vol. 2016, no. 54, p. 120-130
hdl
1887/43697
URL
http://www.sciencedirect.com/science/article/pii/S0959804915009272